Global Life Sciences Analytics Market: Key Developments
In February 2022, Clinixir Company Limited selected Oracle’s innovative clinical research and pharmacovigilance solutions as its eClinical platform. Clinixir chose Oracle Health Sciences Clinical One Cloud Service for its comprehensive, end-to-end technology capabilities and breadth of applications.
In August 2021, Accenture Federal Services (AFS), a subsidiary of Accenture PLC, completed acquisition of Novetta, a McLean, Virginia-based advanced analytics company.
In July 2021, Philips & Cognizant teamed up to develop end-to-end digital health solutions that will enable healthcare organizations and life sciences companies to improve patient care and accelerate clinical trials.
In March 2021, Cleveland Clinic and IBM teamed up to establish the Discovery Accelerator, a joint Cleveland Clinic - IBM centre to fundamentally advancing the pace of the discovery in healthcare and life sciences through the use of artificial intelligence (AI), quantum computing technologies, and high-performance computing on the hybrid cloud.
Global Life Sciences Analytics Market: Key Companies Insights
The global life sciences analytics market is highly competitive. This is attributed to the rising adoption of analytics solutions in pharmaceuticals and clinical trials, as a result, players in the market are focusing on launching novel analytics solutions in the market.
Some of the key players in the global life sciences analytics market are:
Apollo Intelligence, SERMA Group, M3 (EU) Ltd., Dynata, Wipro Limited, SAS Institute Inc., IQVIA, Oracle Corporation, MaxisIT, IBM Corporation, Cognizant, Accenture, EXL Service (SCIOInspire Corp.), and TAKE Solutions Limited, among others.
Life Sciences Analytics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients